Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

International Journal of Infectious Diseases(2024)10.1016/j.ijid.2024.106985Source: DataRank Database

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali is a research paper published in International Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.11)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (68)

Donatien Kazadi,Kadidia Kone,Viviane Callier ORCID,Djénéba Dabitao ORCID,Dehkontee Dennis

Live enrichment

PubMed:38417612 PMC:PMC11100347 OpenAlex:https://openalex.org/W4392234176

National Cancer Institute

Grant: 75N91019D00024

National Institutes of Health

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.ijidonline.com/article/S1201971224000560/pdf

publisherhttp://www.ijidonline.com/article/S1201971224000560/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1201971224000560?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1201971224000560?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ijid.2024.106985

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsVaccine Coverage and Hesitancy

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAdultAntibodies, ViralHumansLiberiaMaliVaccinesDemocratic Republic of the CongoSeroepidemiologic StudiesGuinea

Keywords

SeroprevalenceMedicinePopulationAsymptomaticPandemicHerd immunityDemographyImmunologyEnvironmental healthSerologyInternal medicineAntibodyCoronavirus disease 2019 (COVID-19)DiseaseVaccinesWest AfricaInviteCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Zero hunger

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

FAIR Checklist

Authors (68)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)